首页> 美国卫生研究院文献>Journal of Oncology >Prognostic and Therapeutic Potential of Nuclear Receptors in Head and Neck Squamous Cell Carcinomas
【2h】

Prognostic and Therapeutic Potential of Nuclear Receptors in Head and Neck Squamous Cell Carcinomas

机译:头颈部鳞状细胞癌中核受体的预后和治疗潜力。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Head and neck squamous cell carcinomas are among the most common neoplasms worldwide and characterized by local tumor aggressiveness, high rate of early recurrences, development of metastasis, and second primary cancers. Despite modern therapeutic strategies and sophisticated surgical management, overall survival-rates remained largely unchanged over the last decades. Thus, the need for novel treatment options for this tumor entity is undeniable. A key event in carcinogenesis is the uncontrolled modulation of genetic programs. Nuclear receptors belong to a large superfamily of transcription factors implicated in a broad spectrum of physiological and pathophysiological processes, including cancer. Several nuclear receptors have also been associated with head and neck cancer. This review will summarize their mode of action, prognostic/therapeutic relevance, as well as preclinical and clinical studies currently targeting nuclear receptors in this tumor entity.
机译:头颈部鳞状细胞癌是全球最常见的肿瘤之一,其特征是局部肿瘤侵袭性高,早期复发率高,转移发展和第二原发癌。尽管采用了现代治疗策略和先进的手术管理方法,但在过去的几十年中,总体生存率基本保持不变。因此,不可否认该肿瘤实体需要新的治疗选择。致癌作用中的关键事件是遗传程序的不受控制的调节。核受体属于转录因子的一个大家族,涉及许多广泛的生理和病理生理过程,包括癌症。几种核受体也与头颈癌有关。这篇综述将总结他们的作用方式,预后/治疗相关性,以及目前针对该肿瘤实体中核受体的临床前和临床研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号